FDA Inspection
Cadila Pharmaceuticals LimitedCadila Pharmaceuticals Limited – FDA Inspection, Jul 14, 2017
Record Details
This FDA Inspection record concerns Cadila Pharmaceuticals Limited, with an inspection on July 14, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Courtney N. Long (Company Rep)
- Jennifer C. Adams (Company Rep)
- Melkamu Getie Kebtie (Issuing Officer)
- Xikui Chen (FDA Associated Person)
View Company Profile
ID · e9b41269-ccf9-440a-998d-71b03bdd1872
Inspection Facts
- Inspection number
- 1019141
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Cadila Pharmaceuticals Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2025 | NAI | Bioresearch Monitoring | |
| April 7, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 17, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 14, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 3, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cadila Pharmaceuticals Limited
- FDA Inspection 1293740 - 2025-09-26
- FDA Inspection 1205061 - 2023-04-07
- FDA Inspection 1173461 - 2022-06-17
- FDA Inspection 1120482 - 2020-02-14
- FDA Inspection 1052117 - 2018-05-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.